MCSS: the digital transformation of medication handling
CEO Ulrika Kjellberg tells Health Europa more about how the medication handling has transformed nursing home and residential care in Sweden.
Appva’s fully digital Medication...
Could the ancient remedy of magnolia bark treat drug-resistant epilepsy?
Researchers have published a paper which suggests the ancient Chinese remedy of magnolia bark could help treat drug-resistant epilepsy.
Researchers have published a paper in...
Pharma companies are more profitable than most S&P 500 companies
New research from Bentley University, Massachusetts, USA, reveals that big pharmaceutical companies are more profitable than most Standard & Poor (S&P) 500 companies.
The research...
Smart diabetes management market 2020 is surging
The smart diabetes management market is estimated to reach $11.93bn (€10.74bn) by 2027, according to new research by Data Bridge Market Research.
Data Bridge Market...
Next generation pharmacology research with Tetra Bio-Pharma
Tetra Bio-Pharma are pleased to announce their co-development agreement with MAKScientific – could this agreement be the advancements needed for next generation pharmacology research?
Leaders...
Tetra confirms FDA conditions met for CAUMZ drug
FDA conditions met for Fast Track programme where the patient population has a serious condition with significant morbidity.
Leaders in botanical-derived drug discovery and development,...
European pharmaceutical industry’s shared goals and responsibilities
Nathalie Moll, Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA), explores Europe’s shared goals and shared responsibilities
When EU Commission President,...
MDMA-assisted psychotherapy for PTSD approved by FDA
A new programme will enrol 50 PTSD patients for MDMA-assisted psychotherapy following FDA approval.
The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) was recently granted...
Tetra Bio Pharma receives approval for OTC use in pain drugs
TERPACAN™, from Tetra Bio Pharma, has received approval for over the counter (OTC) use in back and muscle pain, and in hemorrhoids.
TERPACAN™ is expected...
BioNotus: your one-stop partner for contract research
BioNotus combines bioanalysis (data) with pharmacometrics (information) to deliver actionable insights
BioNotus is a contract research organisation which specialises in the bioanalysis of drugs. Johan...
Fish Odour Syndrome: Dermetel aims to give patients a breath of fresh air
Dermetel is launching two Phase I clinical trials that focus on the rare disease, Trimethylaminuria or more commonly known, fish odour syndrome.
Fish odour syndrome...
New partnership announced today is set to reduce the impact of sepsis in the UK
Beckman Coulter, the global leader in clinical diagnostics, announces today its partnership with South West London Pathology (SWLP) to reduce the impact of sepsis in...
Want to hear the latest developments regarding Tetra’s hepatocellular carcinoma drug?
Responsible for 80% of primary malignant liver tumours in adults, hepatocellular carcinoma is a common form of liver cancer – but did you know...
Ketamine may hold potential as treatment for autism and Tourette’s
To this day there is no known cure for either autism or Tourette’s syndrome, however, new research has revealed how a common anaesthetic could...
Nerve pain drug could help restore limb function after spinal cord injury
A mouse study has shown that nerve pain drug gabapentin promotes regeneration of neural circuits.
New research in mice suggests that long-term treatment with gabapentin,...
World’s first magic mushroom nasal spray for PTSD and depression
PTSD and depression are two conditions that are being trialled for treatment with psilocybin.
A ‘magic mushroom’ nasal spray has been designed to make microdosing...
Clinical trials: FDA marks psilocybin for depression treatment
The FDA designation represents a major step forward in mental health research and for patients suffering from depression.
A non-profit medical research centre, the Usona...
New antibiotic on the horizon to combat drug resistance
Today, more and more bacterial pathogens of infectious diseases are becoming resistant to customary antibiotics.
A new discovery, from an international team of researchers, with...
Crohn’s disease: how associated bacteria develop drug resistance
Many patients with Crohn's disease develop resistance to treatments.
Researchers have looked at how Chron’s disease-related bacteria can form drug resistance.
They found that bacteria associated...
Why veterinarians should be at the heart of the drug resistance fightback
When antibiotic resistance could be responsible for up to 10 million deaths a year by 2050 if left unchecked, it is natural to want...
